Diagonal Bio AB's total assets for Q4 2022 were kr34.03M, an increase of 14.29% from the previous quarter. DE:9F1 total liabilities were kr2.78M for the fiscal quarter, a -64.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.